Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Fresenius Medical Care US Finance II, 5.875% 31jan2022, USD
USU31434AC42

  • Placement amount
    700,000,000 USD
  • Outstanding amount
    700,000,000 USD
  • Minimum Settlement Amount
    2,000 USD
  • ISIN RegS
    USU31434AC42
  • CFI RegS
    DBFUGR
  • FIGI RegS
    BBG002DTPP77
  • SEDOL
    B6ZJ467
  • Ticker
    FMEGR 5.875 01/31/22 REGS

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Files

Final Terms

Prospectus

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Fresenius Medical Care US Finance II, Inc. provides financing services. It issues and sells debt securities; and advances the proceeds of issued notes to Fresenius Medical Care AG & Co. KGaA and its subsidiaries. The company ...
Fresenius Medical Care US Finance II, Inc. provides financing services. It issues and sells debt securities; and advances the proceeds of issued notes to Fresenius Medical Care AG & Co. KGaA and its subsidiaries. The company was founded in 2011 and is based in Waltham, Massachusetts. Fresenius Medical Care US Finance II, Inc. is a subsidiary of Fresenius Medical Care AG & Co. KGaA.
Volume
  • Placement amount
    700,000,000 USD
  • Outstanding amount
    700,000,000 USD
Nominal
  • Minimum Settlement Amount
    2,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD
  • Nominal
    1,000 USD

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Placement

  • Placement method
    Open subscription
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • The purpose of placing
    The aggregate net proceeds from the sale of $15 billion principal amount of Dollar-denominated Notes at 100% will be approximately $1482 billion, after payment of fees and estimated expenses in the total amount of approximately $176 million The aggregate net proceeds from the sale of A250 million principal amount of Euro-denominated Notes at 100% will be approximately $3170 million (based on an exchange rate of A1 = $12831 on January 18, 2012), after payment of fees and estimated expenses in the total amount of approximately $38 million The company intends to use the net proceeds of this offering for acquisitions, including the Liberty Acquisition, to refinance indebtedness, including term loan indebtedness under our Amended 2006 Senior Credit Agreement and for general corporate purposes The offering is not conditioned on the closing of the Liberty Acquisition Certain of the initial purchasers and affiliates of the initial purchasers may receive a portion of the net proceeds from this offering in their capacities as agents and/or lenders under our Amended 2006 Senior Credit Agreement or our other indebtedness See “Plan of Distribution and Offer of the Notes” For information regarding our Amended 2006 Senior Credit Agreement and our other outstanding indebtedness, see “Description of Certain Indebtedness” The following table presents the unaudited consolidated capitalization of Fresenius Medical Care AG & Co
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***

Conversion and exchange

  • Conversion terms
    ***

Additional information

***

Latest issues

Identifiers

  • ISIN RegS
    ***
  • ISIN 144A
    ***
  • CUSIP RegS
    ***
  • CUSIP 144A
    ***
  • CFI RegS
    DBFUGR
  • CFI 144A
    DBFUGR
  • FIGI RegS
    BBG002DTPP77
  • FIGI 144A
    BBG002DS04R1
  • WKN RegS
    A1GZRF
  • WKN 144A
    A1GZLU
  • SEDOL
    B6ZJ467
  • Ticker
    FMEGR 5.875 01/31/22 REGS
  • Type of security by CBR
    ***

Bond classification

  • Senior Unsecured
  • Registered
  • Documentary bonds
  • Coupon bonds
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible

Restructuring

***

Registration is required to get access.